T15	Gene 725 729	gene
T1	Peptide 19 45	atrial natriuretic peptide
T20	TranscriptionFactor 67 72	GATA4
T3	OrganicChemical 135 146	acamprosate
T7	Sequence 313 344	single nucleotide polymorphisms
T24	Sequence 346 350	SNPs
T9	ExperimentalMethod 389 392	GWA
T26	OrganicChemical 618 629	acamprosate
T27	OrganicChemical 631 641	naltrexone
T28	Chemical 645 652	placebo
T29	Chemical 588 595	placebo
T14	Sequence 658 688	single nucleotide polymorphism
T30	Sequence 690 700	rs13273672
T31	Sequence 714 717	SNP
T32	Intron 705 713	intronic
T16	Protein 734 756	GATA-binding protein 4
T17	Protein 758 763	GATA4
T33	ExperimentalMethod 858 882	pharmacogenetic analyses
T34	OrganicChemical 954 965	acamprosate
T35	Gene 1010 1029	natriuretic peptide
T36	Promoter 1030 1039	promoters
T38	TranscriptionFactor 1057 1062	GATA4
T39	Peptide 1114 1140	atrial natriuretic peptide
T40	Peptide 1142 1145	ANP
T41	TranscriptionFactor 1185 1190	GATA4
T42	TranscriptionFactor 1250 1255	GATA4
T43	Sequence 1228 1246	genetic variations
T46	OrganicChemical 1306 1317	acamprosate
T49	Peptide 1366 1369	ANP
T53	OrganicChemical 1543 1554	acamprosate
T54	PhysicalContinuant 1147 1153	plasma
T55	PhysicalContinuant 1370 1376	plasma
